Status:
UNKNOWN
Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
Lead Sponsor:
Keratoplasty Alliance International
Conditions:
Corneal Disease
Endothelial Corneal Dystrophy
Eligibility:
All Genders
18+ years
Brief Summary
The goal is to develop a nationwide registry to track longitudinal clinical outcomes of and store imaging data related to numerous corneal conditions. There are two main objectives including the estab...
Detailed Description
Background. Overview of ocular conditions and global statistics Corneal disease is the fifth leading cause of blindness in the world, and approximately 4.5 million individuals have moderate to severe ...
Eligibility Criteria
Inclusion
- All subjects with corneal disease or undergoing corneal transplantation (either penetrating keratoplasty, endothelial keratoplasty \[including DSAEK and DMEK\], or anterior lamellar keratoplasty are eligible to be included in this study. Imaging studies performed pre-operatively, up until 1 year prior to surgery will be collected. Studies may include the following:
- OCT
- Corneal topography
- Specular biomicroscopy
- In vivo confocal biomicroscopy
Exclusion
- Any criteria that does not meet the inclusion criteria above.
Key Trial Info
Start Date :
October 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06101017
Start Date
October 12 2023
End Date
October 31 2025
Last Update
October 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Keratoplasty Alliance International
Baltimore, Maryland, United States, 21210